[U.S. Stock Movement] Arcutis surges on October 15: Analyst Initial Coverage + Zoryve Growth
Bitget异动解读2026/10/15 19:21Arcutis October 15 Surge Analysis
Keywords: Analyst Initiation, Zoryve Growth
1. On October 15, Cantor Fitzgerald initiated coverage on Arcutis for the first time, giving it an "Overweight" rating and setting a target price of $48.
2. On October 15, analysts pointed out that Zoryve's sales growth is strong and its commercial business is expanding rapidly. They believe Arcutis holds a leading position in the branded topical therapeutics market, and see growth opportunities in the dermatology field.
(Disclaimer: This content is generated by AI technology based on publicly available information for reference only and does not constitute investment advice.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like

Moody's expects Nike's revenue and profits to decline through fiscal year 2028
Tesla Vice President of Energy and Charging, Mike Snyder, resigns

Moody’s changes Nike’s outlook to negative and confirms its A2 rating